Inside US FDA’s Return To In-Person Meetings

 
• By Derrick Gingery
hybrid meeting
The FDA will only allow "core participants" with speaking roles to attend hybrid meetings in person. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers